Nutra Pharma Corp.

Acquisition, licensing and commercialisation of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune and infectious diseases

Nutra Pharma (OTCBB: NPHC) is a biotechnology holding company with two subsdiaries. ReceptoPharm, Inc. is developing technologies for the development of drugs for HIV and multiple sclerosis.

NanoLogix, Inc. develops diagnostic test kits designed for the rapid identification of infectious diseases including tuberculosis and mycobacterium avium-intracellulare infection.

Rik J. Deitsch, President and CEO
Paul F. Reid, PhD.
Neil Roth

Rik Deitsch, Chairman
Stewart Lonky, Dr.
Stanley J. Cherelstein

791 Park of Commerce Blvd., Suite 300
Boca Raton, FL 33487
USA
Phone: +1-954-509-0911
Fax: +1-877-895-5647